APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI in Predictive Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI in Predictive Medicine Market Outlook and Growth Opportunities 2026

Report ID 174058870428 December 2025199 pages

Choose your research edition.

Industry ResearchAI in Predictive Medicine Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI in Predictive Medicine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal AI in Predictive Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI in Predictive Medicine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal AI in Predictive Medicine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global AI in Predictive Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI in Predictive Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI in Predictive Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI in Predictive Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI in Predictive Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI in Predictive Medicine market include Tempus, PathAI, Qure.ai, Artera, Athelas, Insilico Medicine, Atomwise, Arcadia and Merck Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI in Predictive Medicine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI in Predictive Medicine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI in Predictive Medicine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI in Predictive Medicine market.

AI in Predictive Medicine Segment by Company

Tempus

PathAI

Qure.ai

Artera

Athelas

Insilico Medicine

Atomwise

Arcadia

Merck Group

Verantos

Imagene

Generate:Biomedicines

Insitro

Ibex Medical Analytics

Achievion Solutions

AI in Predictive Medicine Segment by Type

Machine Learning and Deep Learning

Natural Language Processing

Multimodal Data Fusion

Time Series Model

AI in Predictive Medicine Segment by Application

Disease Risk Prediction

Early Diagnosis

Prognosis Prediction

Treatment Response Prediction

AI in Predictive Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI in Predictive Medicine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI in Predictive Medicine key companies, revenue, market share, and recent developments.

3. To split the AI in Predictive Medicine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI in Predictive Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI in Predictive Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze AI in Predictive Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI in Predictive Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI in Predictive Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI in Predictive Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI in Predictive Medicine industry.

Chapter 3: Detailed analysis of AI in Predictive Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI in Predictive Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI in Predictive Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI in Predictive Medicine Industry Trends Table 2. AI in Predictive Medicine Industry Drivers Table 3. AI in Predictive Medicine Industry Opportunities and Challenges Table 4. AI in Predictive Medicine Industry Restraints Table 5. Global AI in Predictive Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI in Predictive Medicine Revenue Share by Company (2021-2026) Table 7. Global AI in Predictive Medicine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI in Predictive Medicine Key Company Manufacturing Base & Headquarters Table 9. Global AI in Predictive Medicine Company, Product Type & Application Table 10. Global AI in Predictive Medicine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI in Predictive Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Machine Learning and Deep Learning Table 15. Significant Companies of Natural Language Processing Table 16. Significant Companies of Multimodal Data Fusion Table 17. Significant Companies of Time Series Model Table 18. Global AI in Predictive Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global AI in Predictive Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global AI in Predictive Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global AI in Predictive Medicine Sales Value Share by Type (2021-2026) Table 22. Global AI in Predictive Medicine Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Disease Risk Prediction Table 24. Significant Companies of Early Diagnosis Table 25. Significant Companies of Prognosis Prediction Table 26. Significant Companies of Treatment Response Prediction Table 27. Global AI in Predictive Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI in Predictive Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global AI in Predictive Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global AI in Predictive Medicine Sales Value Share by Application (2021-2026) Table 31. Global AI in Predictive Medicine Sales Value Share by Application (2027-2032) Table 32. Global AI in Predictive Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI in Predictive Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global AI in Predictive Medicine Sales Value Share by Region (2021-2026) Table 35. Global AI in Predictive Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global AI in Predictive Medicine Sales Value Share by Region (2027-2032) Table 37. Global AI in Predictive Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global AI in Predictive Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global AI in Predictive Medicine Sales Value Market Share by Country (2021-2026) Table 40. Global AI in Predictive Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global AI in Predictive Medicine Sales Value Market Share by Country (2027-2032) Table 42. Tempus Company Information Table 43. Tempus Business Overview Table 44. Tempus AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Tempus AI in Predictive Medicine Product Portfolio Table 46. Tempus Recent Development Table 47. PathAI Company Information Table 48. PathAI Business Overview Table 49. PathAI AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. PathAI AI in Predictive Medicine Product Portfolio Table 51. PathAI Recent Development Table 52. Qure.ai Company Information Table 53. Qure.ai Business Overview Table 54. Qure.ai AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Qure.ai AI in Predictive Medicine Product Portfolio Table 56. Qure.ai Recent Development Table 57. Artera Company Information Table 58. Artera Business Overview Table 59. Artera AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Artera AI in Predictive Medicine Product Portfolio Table 61. Artera Recent Development Table 62. Athelas Company Information Table 63. Athelas Business Overview Table 64. Athelas AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Athelas AI in Predictive Medicine Product Portfolio Table 66. Athelas Recent Development Table 67. Insilico Medicine Company Information Table 68. Insilico Medicine Business Overview Table 69. Insilico Medicine AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Insilico Medicine AI in Predictive Medicine Product Portfolio Table 71. Insilico Medicine Recent Development Table 72. Atomwise Company Information Table 73. Atomwise Business Overview Table 74. Atomwise AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Atomwise AI in Predictive Medicine Product Portfolio Table 76. Atomwise Recent Development Table 77. Arcadia Company Information Table 78. Arcadia Business Overview Table 79. Arcadia AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Arcadia AI in Predictive Medicine Product Portfolio Table 81. Arcadia Recent Development Table 82. Merck Group Company Information Table 83. Merck Group Business Overview Table 84. Merck Group AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Merck Group AI in Predictive Medicine Product Portfolio Table 86. Merck Group Recent Development Table 87. Verantos Company Information Table 88. Verantos Business Overview Table 89. Verantos AI in Predictive Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Verantos AI in Predictive Medicine Product Portfolio Table 91. Verantos Recent Development Table 92. Imagene Company Information Table 93. Imagene Business Overview Table 94. Imagene AI in Predictive Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Imagene AI in Predictive Medicine Product Portfolio Table 96. Imagene Recent Development Table 97. Generate:Biomedicines Company Information Table 98. Generate:Biomedicines Business Overview Table 99. Generate:Biomedicines AI in Predictive Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Generate:Biomedicines AI in Predictive Medicine Product Portfolio Table 101. Generate:Biomedicines Recent Development Table 102. Insitro Company Information Table 103. Insitro Business Overview Table 104. Insitro AI in Predictive Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Insitro AI in Predictive Medicine Product Portfolio Table 106. Insitro Recent Development Table 107. Ibex Medical Analytics Company Information Table 108. Ibex Medical Analytics Business Overview Table 109. Ibex Medical Analytics AI in Predictive Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Ibex Medical Analytics AI in Predictive Medicine Product Portfolio Table 111. Ibex Medical Analytics Recent Development Table 112. Achievion Solutions Company Information Table 113. Achievion Solutions Business Overview Table 114. Achievion Solutions AI in Predictive Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Achievion Solutions AI in Predictive Medicine Product Portfolio Table 116. Achievion Solutions Recent Development Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. AI in Predictive Medicine Product Image Figure 2. Global AI in Predictive Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI in Predictive Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global AI in Predictive Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Machine Learning and Deep Learning Image Figure 8. Natural Language Processing Image Figure 9. Multimodal Data Fusion Image Figure 10. Time Series Model Image Figure 11. Global AI in Predictive Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global AI in Predictive Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global AI in Predictive Medicine Sales Value Share by Type (2021-2032) Figure 14. Disease Risk Prediction Image Figure 15. Early Diagnosis Image Figure 16. Prognosis Prediction Image Figure 17. Treatment Response Prediction Image Figure 18. Global AI in Predictive Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI in Predictive Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global AI in Predictive Medicine Sales Value Share by Application (2021-2032) Figure 21. Global AI in Predictive Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global AI in Predictive Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America AI in Predictive Medicine Sales Value (2021-2032) & (US$ Million) Figure 24. North America AI in Predictive Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe AI in Predictive Medicine Sales Value (2021-2032) & (US$ Million) Figure 26. Europe AI in Predictive Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific AI in Predictive Medicine Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific AI in Predictive Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America AI in Predictive Medicine Sales Value (2021-2032) & (US$ Million) Figure 30. South America AI in Predictive Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa AI in Predictive Medicine Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa AI in Predictive Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt AI in Predictive Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Machine Learning and Deep Learning
  • Natural Language Processing
  • Multimodal Data Fusion
  • Time Series Model
Applications
  • Disease Risk Prediction
  • Early Diagnosis
  • Prognosis Prediction
  • Treatment Response Prediction
Companies covered
  • Tempus
  • PathAI
  • Qure.ai
  • Artera
  • Athelas
  • Insilico Medicine
  • Atomwise
  • Arcadia
  • Merck Group
  • Verantos
  • Imagene
  • Generate:Biomedicines
  • Insitro
  • Ibex Medical Analytics
  • Achievion Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI in Predictive Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI in Predictive Medicine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI in Predictive Medicine Market Dynamics
  1. 2.1 AI in Predictive Medicine Industry Trends
  2. 2.2 AI in Predictive Medicine Industry Drivers
  3. 2.3 AI in Predictive Medicine Industry Opportunities and Challenges
  4. 2.4 AI in Predictive Medicine Industry Restraints
3 AI in Predictive Medicine Market by Company
  1. 3.1 Global AI in Predictive Medicine Company Revenue Ranking in 2025
  2. 3.2 Global AI in Predictive Medicine Revenue by Company (2021-2026)
  3. 3.3 Global AI in Predictive Medicine Company Ranking (2024-2026)
  4. 3.4 Global AI in Predictive Medicine Company Manufacturing Base and Headquarters
  5. 3.5 Global AI in Predictive Medicine Company Product Type and Application
  6. 3.6 Global AI in Predictive Medicine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI in Predictive Medicine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI in Predictive Medicine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI in Predictive Medicine Market by Type
  1. 4.1 AI in Predictive Medicine Type Introduction
  2. 4.1.1 Machine Learning and Deep Learning
  3. 4.1.2 Natural Language Processing
  4. 4.1.3 Multimodal Data Fusion
  5. 4.1.4 Time Series Model
  6. 4.2 Global AI in Predictive Medicine Sales Value by Type
  7. 4.2.1 Global AI in Predictive Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global AI in Predictive Medicine Sales Value by Type (2021-2032)
  9. 4.2.3 Global AI in Predictive Medicine Sales Value Share by Type (2021-2032)
5 AI in Predictive Medicine Market by Application
  1. 5.1 AI in Predictive Medicine Application Introduction
  2. 5.1.1 Disease Risk Prediction
  3. 5.1.2 Early Diagnosis
  4. 5.1.3 Prognosis Prediction
  5. 5.1.4 Treatment Response Prediction
  6. 5.2 Global AI in Predictive Medicine Sales Value by Application
  7. 5.2.1 Global AI in Predictive Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI in Predictive Medicine Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI in Predictive Medicine Sales Value Share by Application (2021-2032)
6 AI in Predictive Medicine Regional Value Analysis
  1. 6.1 Global AI in Predictive Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI in Predictive Medicine Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI in Predictive Medicine Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI in Predictive Medicine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI in Predictive Medicine Sales Value (2021-2032)
  7. 6.3.2 North America AI in Predictive Medicine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI in Predictive Medicine Sales Value (2021-2032)
  10. 6.4.2 Europe AI in Predictive Medicine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI in Predictive Medicine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI in Predictive Medicine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI in Predictive Medicine Sales Value (2021-2032)
  16. 6.6.2 South America AI in Predictive Medicine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI in Predictive Medicine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI in Predictive Medicine Sales Value Share by Country, 2025 VS 2032
7 AI in Predictive Medicine Country-level Value Analysis
  1. 7.1 Global AI in Predictive Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI in Predictive Medicine Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI in Predictive Medicine Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI in Predictive Medicine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI in Predictive Medicine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI in Predictive Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI in Predictive Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tempus
  2. 8.1.1 Tempus Company Information
  3. 8.1.2 Tempus Business Overview
  4. 8.1.3 Tempus AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tempus AI in Predictive Medicine Product Portfolio
  6. 8.1.5 Tempus Recent Developments
  7. 8.2 PathAI
  8. 8.2.1 PathAI Company Information
  9. 8.2.2 PathAI Business Overview
  10. 8.2.3 PathAI AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PathAI AI in Predictive Medicine Product Portfolio
  12. 8.2.5 PathAI Recent Developments
  13. 8.3 Qure.ai
  14. 8.3.1 Qure.ai Company Information
  15. 8.3.2 Qure.ai Business Overview
  16. 8.3.3 Qure.ai AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qure.ai AI in Predictive Medicine Product Portfolio
  18. 8.3.5 Qure.ai Recent Developments
  19. 8.4 Artera
  20. 8.4.1 Artera Company Information
  21. 8.4.2 Artera Business Overview
  22. 8.4.3 Artera AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Artera AI in Predictive Medicine Product Portfolio
  24. 8.4.5 Artera Recent Developments
  25. 8.5 Athelas
  26. 8.5.1 Athelas Company Information
  27. 8.5.2 Athelas Business Overview
  28. 8.5.3 Athelas AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Athelas AI in Predictive Medicine Product Portfolio
  30. 8.5.5 Athelas Recent Developments
  31. 8.6 Insilico Medicine
  32. 8.6.1 Insilico Medicine Company Information
  33. 8.6.2 Insilico Medicine Business Overview
  34. 8.6.3 Insilico Medicine AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Insilico Medicine AI in Predictive Medicine Product Portfolio
  36. 8.6.5 Insilico Medicine Recent Developments
  37. 8.7 Atomwise
  38. 8.7.1 Atomwise Company Information
  39. 8.7.2 Atomwise Business Overview
  40. 8.7.3 Atomwise AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Atomwise AI in Predictive Medicine Product Portfolio
  42. 8.7.5 Atomwise Recent Developments
  43. 8.8 Arcadia
  44. 8.8.1 Arcadia Company Information
  45. 8.8.2 Arcadia Business Overview
  46. 8.8.3 Arcadia AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Arcadia AI in Predictive Medicine Product Portfolio
  48. 8.8.5 Arcadia Recent Developments
  49. 8.9 Merck Group
  50. 8.9.1 Merck Group Company Information
  51. 8.9.2 Merck Group Business Overview
  52. 8.9.3 Merck Group AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Group AI in Predictive Medicine Product Portfolio
  54. 8.9.5 Merck Group Recent Developments
  55. 8.10 Verantos
  56. 8.10.1 Verantos Company Information
  57. 8.10.2 Verantos Business Overview
  58. 8.10.3 Verantos AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Verantos AI in Predictive Medicine Product Portfolio
  60. 8.10.5 Verantos Recent Developments
  61. 8.11 Imagene
  62. 8.11.1 Imagene Company Information
  63. 8.11.2 Imagene Business Overview
  64. 8.11.3 Imagene AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Imagene AI in Predictive Medicine Product Portfolio
  66. 8.11.5 Imagene Recent Developments
  67. 8.12 Generate:Biomedicines
  68. 8.12.1 Generate:Biomedicines Company Information
  69. 8.12.2 Generate:Biomedicines Business Overview
  70. 8.12.3 Generate:Biomedicines AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Generate:Biomedicines AI in Predictive Medicine Product Portfolio
  72. 8.12.5 Generate:Biomedicines Recent Developments
  73. 8.13 Insitro
  74. 8.13.1 Insitro Company Information
  75. 8.13.2 Insitro Business Overview
  76. 8.13.3 Insitro AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Insitro AI in Predictive Medicine Product Portfolio
  78. 8.13.5 Insitro Recent Developments
  79. 8.14 Ibex Medical Analytics
  80. 8.14.1 Ibex Medical Analytics Company Information
  81. 8.14.2 Ibex Medical Analytics Business Overview
  82. 8.14.3 Ibex Medical Analytics AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ibex Medical Analytics AI in Predictive Medicine Product Portfolio
  84. 8.14.5 Ibex Medical Analytics Recent Developments
  85. 8.15 Achievion Solutions
  86. 8.15.1 Achievion Solutions Company Information
  87. 8.15.2 Achievion Solutions Business Overview
  88. 8.15.3 Achievion Solutions AI in Predictive Medicine Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Achievion Solutions AI in Predictive Medicine Product Portfolio
  90. 8.15.5 Achievion Solutions Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst